Radiotherapy treatment of adrenal gland metastases from hepatocellular carcinoma: clinical features and prognostic factors

被引:0
作者
Le-Yuan Zhou
Zhao-Chong Zeng
Jia Fan
Bing Chen
Sheng-xiang Rao
Jian He
Ping Yang
Jia-zhou Hou
Zhi-feng Wu
Jian-ying Zhang
Yong Hu
机构
[1] The Affiliated Hospital of Jiangnan University (The 4th people’s hospital of Wuxi City),Department of Radiation Oncology
[2] Zhongshan Hospital,Department of Radiation Oncology
[3] Fudan University,Department of Radiology
[4] Liver Cancer Institute,undefined
[5] Zhongshan Hospital,undefined
[6] Fudan University,undefined
[7] Zhongshan Hospital,undefined
[8] Fudan University,undefined
来源
BMC Cancer | / 14卷
关键词
Hepatocellular carcinoma; Adrenal gland; Metastasis; Radiotherapy; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 141 条
[1]  
Shuto T(1998)Changes and results of surgical strategies for hepatocellular carcinoma: results of a 15-year study on 452 consecutive patients Surg Today 28 1124-1129
[2]  
Hirohashi K(2004)A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma Cancer J 10 307-316
[3]  
Kubo S(2008)Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators Arch Surg 143 182-188
[4]  
Tanaka H(2000)Extrahepatic metastases of hepatocellular carcinoma Radiology 216 698-703
[5]  
Tsukamoto T(2002)Management of adrenal metastasis from hepatocellular carcinoma Surg Today 32 1035-1041
[6]  
Yamamoto T(2007)What is the best treatment modality for adrenal metastasis from hepatocellular carcinoma? J Surg Onco 96 32-36
[7]  
Ikebe T(2005)Radiation therapy for adrenal gland metastases from hepatocellular carcinoma Jpn J Clin Oncol 35 61-67
[8]  
Kinoshita H(2000)The diagnostic criteria and stages of primary hepatoma in the 4 Chin J Gen Surg 15 238-239
[9]  
Zeng ZC(2000) National Conference of Liver Cancer: Problems and Discussion J Natl Cancer Inst 92 205-216
[10]  
Tang ZY(2005)New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada Int J Radiat Oncol Biol Phys 63 1067-1076